Teprotumumab-Trbw

Brand name: Tepezza

Rank #410 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$21.4M

Total Cost

Share:

389

Total Claims

$21.4M

Total Cost

24

Prescribers

$55K

Cost per Claim

0

Beneficiaries

389

30-Day Fills

$892K

Avg Cost/Provider

16

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$21.4M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $21.4M total

🔎 Data Overview

💰

At $55,010 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $891,615 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Teprotumumab-Trbw

#ProviderSpecialtyLocationClaimsCost
1Kavita KalraHematology-OncologyBaltimore, MD35$2.1M
2Sathyadeepak RameshOphthalmologySomerset, NJ29$1.9M
3Peter HildebrandOphthalmologyLas Vegas, NV30$1.9M
4Bryan VekoviusOphthalmologyShreveport, LA29$1.4M
5Susan AndracchiOphthalmologyWilmington, NC16$971K
6Jeremy TanOphthalmologyOklahoma City, OK15$895K
7Nicholas RameyOphthalmologyRoanoke, VA15$876K
8Lisa MansuetoOphthalmologyTempe, AZ16$870K
9David SchlessingerOphthalmologyWoodbury, NY11$843K
10Gideon SchneckOphthalmologyEast Setauket, NY16$817K
11Timothy McdevittOphthalmologyHonolulu, HI16$786K
12Lea Ann LopeOphthalmologyGreensburg, PA16$782K
13Esra Karslioglu FrenchEndocrinologyPittsburgh, PA13$742K
14David WeinbergOphthalmologyConcord, NH12$726K
15Larry MeyerOphthalmologyBranson, MO13$703K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
407Ondansetron (Ondansetron Odt)$21.5M1,261,950
408Asciminib Hydrochloride (Scemblix)$21.4M830
409Cephalexin (Cephalexin)$21.4M2,407,718
410Teprotumumab-Trbw (Tepezza)$21.4M389
411Nystatin (Nystatin)$21.4M908,177
412Desvenlafaxine Succinate (Desvenlafaxine Succinate Er)$21.3M257,580
413Sotorasib (Lumakras)$21.3M1,188

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology